Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03101839
Title Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid Tumours
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca

Advanced Solid Tumor

lung non-small cell carcinoma



Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Sarasota Florida 34232 United States Details
Research Site Boston Massachusetts 02215 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site London W1G 6AD United Kingdom Details
Research Site Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from for the field